Ko, In Ok
816  Ergebnisse:
Personensuche X
?
 
?
4

Porphyrin-Based Tumor-Targeting Theranostic Agent: Gd-TDAP:

Kim, Soyeon ; Yang, Ji-ung ; Ahn, Jae Hun...
ACS Medicinal Chemistry Letters.  12 (2021)  9 - p. 1459-1463 , 2021
 
?
 
?
 
?
10

Preliminary19F-MRS Study of Tumor Cell Proliferation with 3..:

Ko, In Ok ; Jung, Ki-Hye ; Kim, Mi Hyun...
Contrast Media & Molecular Imaging.  2017 (2017)  - p. 1-7 , 2017
 
?
11

Improved tumor-targeting MRI contrast agents: Gd(DOTA) conj..:

Park, Ji-Ae ; Lee, Yong Jin ; Ko, In Ok...
Biochemical and Biophysical Research Communications.  455 (2014)  3-4 - p. 246-250 , 2014
 
?
12

Feasibility of CBCT dosimetry for IMRT using a normoxic pol..:

Bong, Ji Hye ; Kwon, Soo-Il ; Kim, Kum Bae...
Journal of the Korean Physical Society.  63 (2013)  5 - p. 1083-1087 , 2013
 
?
13

Synthesis and In Vitro Activity Evaluation of 2′,3′-C-Dimet..:

Ko, Ok Hyun ; Hong, Joon Hee
Nucleosides, Nucleotides and Nucleic Acids.  28 (2009)  8 - p. 761-771 , 2009
 
?
14

Poor Outcomes for IgD Multiple Myeloma Patients Following H..:

Chong, Yong Pil ; Kim, Shin ; Ko, Ok Bae...
Journal of Korean Medical Science.  23 (2008)  5 - p. 819 , 2008
 
?
15

ESHAP Salvage Therapy for Refractory and Relapsed Non-Hodgk..:

Park, Sang Hyoung ; Kim, Shin ; Ko, Ok Bae...
The Korean Journal of Internal Medicine.  21 (2006)  3 - p. 159 , 2006
 
1-15